Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9770130 | 1.00 | LMNA (0.33) | LMNACA2 | |
| SCHEMBL1471228 | 1.00 | LMNA (0.33) | LMNACA2 | |
| SCHEMBL12977807 | 1.00 | LMNA (0.33) | LMNACA2 | |
| SCHEMBL5945084 | 1.00 | LMNA (0.33) | LMNACA2 | |
| SCHEMBL12977792 | 1.00 | LMNA (0.33) | LMNACA2 | |
| SCHEMBL3475186 | 1.00 | LMNA (0.33) | LMNACA2 | |
| SCHEMBL12978019 | 1.00 | LMNA (0.33) | LMNACA2 | |
| SCHEMBL5945109 | 0.97 | — | — | |
| SCHEMBL3868481 | 0.89 | — | — | |
| SCHEMBL11387395 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11710854-B2 | Functional epoxides in catalyst-based electrolyte compositions for Li-ion batteries | ENEVATE CORPORATION (US) | 2023-07-25 | — | — | US | claimed |
| US-20220140392-A1 | FUNCTIONAL EPOXIDES IN CATALYST-BASED ELECTROLYTE COMPOSITIONS FOR LI-ION BATTERIES | ENEVATE CORPORATION | 2022-05-05 | — | — | US | claimed |
| US-11710854-B2 | Functional epoxides in catalyst-based electrolyte compositions for Li-ion batteries | ENEVATE CORPORATION (US) | 2023-07-25 | — | — | US | disclosed |
| US-20220140392-A1 | FUNCTIONAL EPOXIDES IN CATALYST-BASED ELECTROLYTE COMPOSITIONS FOR LI-ION BATTERIES | ENEVATE CORPORATION | 2022-05-05 | — | — | US | disclosed |
| US-9138398-B2 | Cationic alcohols and uses thereof | LIVING PROOF, INC. (US) | 2015-09-22 | — | — | US | disclosed |
| US-20130156719-A1 | CATIONIC ALCOHOLS AND USES THEREOF | LIVING PROOF, INC. (US) | 2013-06-20 | — | — | US | disclosed |
| US-8404221-B2 | Cationic alcohols and uses thereof | LIVING PROOF, INC. (US) | 2013-03-26 | — | — | US | disclosed |
| US-20120276036-A1 | CATIONIC ALCOHOLS AND USES THEREOF | LIVING PROOF, INC. (US) | 2012-11-01 | — | — | US | disclosed |
| US-8242309-B2 | Cationic alcohols and uses thereof | LIVING PROOF, INC. (US) | 2012-08-14 | — | — | US | disclosed |
| US-20110070179-A1 | CATIONIC ALCOHOLS AND USES THEREOF | LIVING PROOF, INC. (US) | 2011-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130156719-A1 | CATIONIC ALCOHOLS AND USES THEREOF | ADH1A, ADH1C, TRPV1 | LMNA 1620/4885CA2 2899/4885 |
| US-20120276036-A1 | CATIONIC ALCOHOLS AND USES THEREOF | ADH1A, ADH1C, TRPV1 | LMNA 1620/4885CA2 2899/4885 |
| US-20110070179-A1 | CATIONIC ALCOHOLS AND USES THEREOF | ADH1A, ADH1C, TRPV1 | LMNA 1620/4885CA2 2899/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.